Latest Funding And Capital News

McLaren Minerals has successfully raised A$3.6 million through an oversubscribed entitlement offer, positioning the company to advance its McLaren titanium project in Western Australia.

GoldArc Resources has secured a strategic partnership with BML Ventures to fast-track the Mt Stirling Project, backed by a $2.5 million non-dilutive funding facility that supports both development and broader exploration.

Polymetals Resources has raised $34.4 million through a share placement to boost exploration and production at its Endeavor Silver Zinc Mine, attracting strong institutional demand.

VEEM Limited reported a year of consolidation in FY25 with solid second-half growth driven by new defence contracts and the promising launch of its VEEM Extreme propulsion system. Despite a revenue dip, the company is poised for a stronger FY26 backed by strategic US defence partnerships and product innovation.

L1 Long Short Fund Limited has updated its dividend notification to include the Dividend Reinvestment Plan price, confirming a fully franked quarterly payout and new issue securities.

Austral Gold has received TSX Venture Exchange approval to issue 1,025,077 shares as repayment of accrued interest on convertible notes, following a recent principal conversion. This move reflects ongoing capital management efforts amid the company’s growth strategy.

Alara Resources’ Oman joint venture has secured an additional $36.4 million loan facility to fund key capital projects and sustain operations at the Al Wash-hi Majaza Copper Gold Project.

Plenti Group Limited has reported a striking 147% increase in cash profit before tax for the first half of FY26, driven by record loan originations and robust credit performance. The fintech lender’s loan portfolio surged 24%, positioning it on track for a $3 billion milestone by March 2026.

Plenti Group Limited has reported a remarkable half-year performance for FY26, with revenues up 20% and profit soaring over tenfold to $10.5 million. The fintech lender’s loan portfolio expanded 24%, driven by strong demand across automotive, renewable energy, and personal loans.

Argent BioPharma has locked in an A$11 million convertible financing facility to finalize its strategic acquisition of AusCann assets and accelerate its growth plans, including a potential US stock exchange listing.

Algorae Pharmaceuticals has announced a non-renounceable Loyalty Options Offer to eligible shareholders, aiming to raise up to $337,678 before costs, with potential additional capital of $4.7 million if all options are exercised. The capital raise supports the company’s pharmaceutical and AI research and development ambitions.

Equity Trustees Limited announces an off-market buy-back offer for MA Credit Income Trust units, allowing eligible unitholders to sell up to 5% of total units at net asset value as of 31 December 2025.